These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7232639)

  • 1. Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings].
    Branchey MH; Branehey LB; Richardson MA
    Psychopharmacol Bull; 1981 Jan; 17(1):118-20. PubMed ID: 7232639
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients.
    Branchey MH; Branchey LB; Richardson MA
    Am J Psychiatry; 1981 May; 138(5):608-12. PubMed ID: 7015884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
    Tuason VB; Escobar JI; Garvey M; Schiele B
    J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loxapine concentrate in acute schizophrenia.
    O'Connell RA; Jeewa M; Allen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
    Paprocki J; Versiani M
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
    Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F
    Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid tranquilization: a comparison of thiothixene with loxapine.
    Dubin WR; Weiss KJ
    J Clin Psychiatry; 1986 Jun; 47(6):294-7. PubMed ID: 3711026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
    Wittkopp TA
    J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
    Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
    J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive myoclonus.
    Little JT; Jankovic J
    Mov Disord; 1987; 2(4):307-11. PubMed ID: 3504556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of loxapine succinate in the treatment of 30 cases of psychotic states].
    Escande M; Granier F; Gardes JP; Boscredon J; Concina M
    Ann Med Psychol (Paris); 1983 Mar; 141(3):309-22. PubMed ID: 6357022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract]   [Full Text] [Related]  

  • 13. Parenteral loxapine in severely disturbed schizophrenic patients.
    Deniker P; Loo H; Cottereau MJ
    J Clin Psychiatry; 1980 Jan; 41(1):23-6. PubMed ID: 6101324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high dose loxapine in refractory schizophrenic patients.
    Lehmann CR; Ereshefsky L; Saklad SR; Mings TE
    Am J Psychiatry; 1981 Sep; 138(9):1212-4. PubMed ID: 7270726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene.
    van der Velde CD; Kiltie H
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Loxapine succinate: a new neuroleptic].
    Cottereau MJ; Poirier MF; Lôo H; Deniker P
    Encephale; 1979; 5(3):251-67. PubMed ID: 39739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 20. Loxapine succinate in the treatment of chronic schizophrenia.
    Nair NP; Decker BL; Schwartz G
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):802-9. PubMed ID: 12919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.